News
-
-
PRESS RELEASE
Original-Research: Verve Group SE (von First Berlin Equity Research GmbH): Kaufen
First Berlin Equity Research GmbH releases a research update on Verve Group SE, confirming BUY rating with a target price of €5.80. Successful placement of 12.9m new shares at SEK28 with institutional investors -
-
PRESS RELEASE
Oxurion signs a letter of intent for the planned acquisition of a preclinical microbiology CRO to diversify and strengthen its presence in the Toulouse region
Oxurion NV announces LOI to acquire 70% share capital of preclinical microbiology services company. Economic details of the transaction and growth projections disclosed -
-
-
-
-
-